Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ocrevus
Pharma
Roche's high-dose version of Ocrevus flunks phase 3 trial
Roche had high hopes for its high dose version of multiple sclerosis powerhouse Ocrevus, but a trial of the new formulation has come up short.
Kevin Dunleavy
Apr 2, 2025 3:26pm
MS meds send CNS market toward strongest growth in years
Mar 26, 2025 10:48am
Roche's Vabysmo will rise above Eylea biosim threat, exec says
Oct 23, 2024 11:24am
Roche doubles down with subcutaneous FDA nod for MS star Ocrevus
Sep 13, 2024 1:50pm
Sales for Roche's Vabysmo rise again, but momentum is stalled
Jul 25, 2024 11:45am
Roche touts near-complete MS suppression for injectable Ocrevus
Apr 17, 2024 11:00am
